23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | +0.24% | - | - | - |
^GSPC | +0.70% | +4.01% | +26.14% | +5604.00% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 146.97 | -2.73 | -1.82% | 16:00 GMT-4 | 8.97M | 7.46M | 353.71B |
ABBV | AbbVie Inc. | 157.06 | -1.20 | -0.76% | 16:00 GMT-4 | 3.60M | 5.62M | 277.35B |
PFE | Pfizer Inc. | 28.88 | +0.19 | +0.66% | 16:00 GMT-4 | 22.31M | 42.31M | 163.65B |
SNY | Sanofi | 48.54 | -0.46 | -0.94% | 16:00 GMT-4 | 1.42M | 1.99M | 121.97B |
REGN | Regeneron Pharmaceuticals, Inc. | 985.02 | +4.45 | +0.45% | 16:00 GMT-4 | 255.41k | 443.02k | 108.54B |
GSK | GlaxoSmithKline plc | 45.12 | -0.03 | -0.07% | 16:00 GMT-4 | 2.12M | 3.19M | 93.74B |
GILD | Gilead Sciences, Inc. | 65.68 | -0.49 | -0.74% | 16:00 GMT-4 | 5.97M | 6.91M | 81.83B |
MRNA | Moderna, Inc. | 166.61 | +2.60 | +1.59% | 16:00 GMT-4 | 4.96M | 3.92M | 63.85B |
TAK | Takeda Pharmaceutical Company Limited | 13.12 | +0.10 | +0.77% | 16:00 GMT-4 | 1.56M | 1.55M | 41.31B |
BNTX | BioNTech SE | 96.95 | -2.05 | -2.07% | 16:00 GMT-4 | 1.25M | 672.19k | 23.36B |
NVAX | Novavax, Inc. | 15.5 | +0.35 | +2.31% | 16:00 GMT-4 | 12.66M | 12.91M | 2.28B |
VIR | Vir Biotechnology, Inc. | 10.55 | -0.10 | -0.94% | 16:00 GMT-4 | 458.59k | 936.15k | 1.44B |
INO | Inovio Pharmaceuticals, Inc. | 11 | +0.04 | +0.36% | 16:00 GMT-4 | 222.32k | 440.11k | 285.02M |
In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]
Key Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to Equity Current share...